GUIDETTI, ANNA

GUIDETTI, ANNA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Risultati 1 - 20 di 32 (tempo di esecuzione: 0.14 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 1-gen-2004 C. Carlo-StellaA. GuidettiA.M. Gianni + Article (author) -
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma : long-term outcomes and graft-versus-host disease-free/relapse-free survival 1-mag-2018 Spina, FrancescoRADICE, TOMMASODe Philippis, ChiaraSOLDARINI, MARTINADi Chio, Maria ChiaraGuidetti, AnnaCorradini, Paolo + Article (author) -
Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes? 1-ott-2019 Guidetti, AnnaCorradini, Paolo + Article (author) -
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination: a phase I trial in metastatic melanoma 15-ago-2004 C. Carlo-StellaA. GuidettiA. Gianni + Article (author) -
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics 25-apr-2022 Guidetti, AnnaBramanti, StefaniaMorello, LuciaDerenzini, EnricoCorradini, Paolo + Article (author) -
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial 1-gen-2003 C. Carlo-StellaA. GuidettiA.M. Gianni + Article (author) -
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients 20-mar-2001 Guidetti A. + Article (author) -
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma 1-gen-2012 C. Carlo-StellaA. GuidettiA.M. Gianni + Article (author) -
Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma 1-nov-2017 A. GuidettiE.V.M. Paterno'P. Corradini + Article (author) -
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma : long-term follow-up 1-giu-2010 C. Carlo StellaA. GuidettiA. Gianni + Article (author) -
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma 1-gen-2021 Corradini, PaoloDerenzini, EnricoGuidetti, AnnaRambaldi, AlessandroTarella, Corrado + Article (author) -
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression 1-nov-2016 F. MauraA. GuidettiA. PellegrinelliM. PennisiC. CaprioliL. FarinaN. BolliCABRAS, ANTONELLO DOMENICOP. Corradini + Article (author) -
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion : an outpatient preparative regimen for autologous hematopoietic cell transplantation 1-gen-2008 A. GuidettiC. TarellaC. Carlo StellaA. Gianni + Article (author) -
Inflammation and lymphoma: Therapeutic implications 1-gen-2015 Guidetti A. + Book Part (author) -
Interferon gamma enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody ID09C3 1-gen-2007 A. GuidettiC. LavazzaP. CorradiniA.M. Gianni + Article (author) -
Interferon γ enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody 1D09C3 1-gen-2007 C. Carlo-StellaA. GuidettiC. LavazzaD. SiaP. CorradiniA.M. Gianni + Article (author) -
Long-term results of autologous hematopoietic stem-cell transplantation after high-dose 90Y-ibritumomab tiuxetan for patients with poor-risk non-Hodgkin lymphoma not eligible for high-dose BEAM 10-ago-2013 A. GuidettiC. TarellaC. Carlo-StellaA.M. Gianni + Article (author) -
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with Defibrotide and recombinant human granulocyte colony-stimulating factor 1-gen-2004 C. Carlo-StellaA. GuidettiA.M. Gianni + Article (author) -
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts 1-ago-2013 S.L. LocatelliA. GiacominiA. GuidettiA. GianniC. Carlo Stella + Article (author) -
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 15-nov-2014 A. GuidettiC. Carlo-StellaL. FarinaL. GiordanoP. CorradiniA.M. Gianni + Article (author) -